More Transparency for Clinical Trial Data: The Decision by the European Medicines Agency to Make Clinical Trial Reports Publicly Available Could Provide a Boon for Biomedical Research

EMBO Reports- United States

doi 10.15252/embr.201439894

Full Text

Abstract

Available in

Date

Authors

Publisher

EMBO

Related search

Php31 - Impact of European Medicines Agency (Ema) Clinical Trial Transparency Policies on Health Technology Assessment (Hta) Decisions in Germany

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Atable: Create Tables for Clinical Trial Reports

R Journal
UncertaintyNumerical AnalysisStatisticsProbability
2019English

European Medicines Agency Policies for Clinical Trials Leave Women Unprotected

Journal of Epidemiology and Community Health
EpidemiologyPublic HealthOccupational HealthEnvironmental
2006English

Clinical Trial Transparency in the Americas: The Need to Coordinate Regulatory Spheres

British Medical Journal
Medicine
2018English

Clinical Trial Transparency: A Reassessment of Industry Compliance With Clinical Trial Registration and Reporting Requirements in the United States

BMJ Open
Medicine
2017English

Editor's Note ...Clinical Trial Reports: A New Section

Oncologist
Cancer ResearchMedicineOncology
2012English

A FLexible Framework for Managing Temporal Clinical Trial Data

International Journal of Electronic Healthcare
Health PolicyHealth Informatics
2005English

2011 Late-Breaking Clinical Trial/Clinical Science: Special Reports Abstracts

Circulation
Cardiovascular MedicinePhysiologyCardiology
2011English

A Tool for Suggesting Ayurvedic Remedies From Curated and Classified Clinical Trial Reports

International Journal of Engineering and Technology(UAE)
ArchitectureHardwareEngineeringChemical EngineeringBiotechnologyEnvironmental EngineeringComputer Science
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy